| Stock Price Details |
|
Chart |
|
|
Last Price (RS)
|
1,501.20
|
|
Change (%)
|
-53.00 (-3.41%)
|
|
Best Buy (RS)
|
0(x0)
|
|
Best Sell (RS)
|
0(x0)
|
|
Today's Range (RS)
|
1,493.75
-
1,548.40
|
|
52-Week Range (RS)
|
1,310.05
-
1,702.00
|
|
Beta (1 Year)
|
0.64
|
|
|
|
|
|
| Index Details |
| BSE 100, BSE 500, BSE 200, BSE HC, BSE DOLLEX, BSE Shariah 50, BSE GREENEX, bse carbonex |
| News |
|
Corporate Details |
| Cipla Ltd - Cipla Limited - News Verification |
| Cipla Ltd - Intimation Under Regulation 30 Read With Schedule III Of The SEBI (Listing Obligations And Disclosure Requir... |
| Cipla Ltd - Cipla Limited - Analysts/Institutional Investor Meet/Con. Call Updates |
| Cipla consolidated net profit rises 10.19% in the June 2025 quarter |
| Cipla gains after Q1 PAT rises 10% YoY to Rs 1,298 crore |
| Cipla Ltd - Cipla Limited - Investor Presentation |
| Cipla Ltd - Cipla Limited - Analysts/Institutional Investor Meet/Con. Call Updates |
| Cipla Ltd - Cipla Limited - Press Release |
| Cipla Ltd - Cipla Limited - Investor Presentation |
| Cipla Ltd - Cipla Limited - Outcome of Board Meeting |
|
|
|
| Incoporation Year : 1935 |
| Chairman : Y K Hamied |
| Ownership Group : Indian Private |
| Sector : MAN |
| Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln |
| Registered Office |
Cipla Ltd
Cipla House Peninsula Buss Par,
Ganpatrao Kadam Mg Lower Parel,
Mumbai,
Maharashtra-400013 |
Phone:91-22-24826000
Fax:91-22-24826120 |
| E-Mail : cosecretary@cipla.com, contactus@cipla.com |
| URL : http://www.cipla.com |
|
| Investor Returns |
|
| |
Date |
Price |
Returns (%) |
| 1Week |
25-Jul-2025 |
1531.10 |
-1.95 |
| 1Month |
01-Jul-2025 |
1515.95 |
-0.97 |
| 3Month |
02-May-2025 |
1525.70 |
-1.61 |
| 6Month |
01-Feb-2025 |
1437.85 |
4.41 |
| 1Year |
01-Aug-2024 |
1546.15 |
-2.91 |
|
|
|
|
| Mutual Funds Holding |
|
| Scheme Name |
% Holding |
Market Value (Rs Cr.) |
| Motilal Oswal Quant Fund |
1.00 |
1.48 |
| DSP Nifty Healthcare Index Fund |
8.56 |
0.71 |
| AXIS Large & Mid Cap Fund |
0.63 |
94.43 |
| Mahindra Manulife Aggressive Hybrid Fund |
0.98 |
17.62 |
| AXIS Children's Fund - Lock in |
0.84 |
7.77 |
|
|
|
|
| Groups : Pharmaceuticals - Indian - Bulk Drugs & Formln |
|
| Company |
Last Price |
Change (%) |
52Week High |
52Week Low |
Market Cap (Rs Cr.) |
| Sun Pharmaceutical Industries Ltd |
1,629.05 |
-4.49 |
1,960.20 |
1,555.00 |
390,863.66 |
| Mankind Pharma Ltd |
2,562.30 |
-0.21 |
3,050.00 |
1,910.10 |
105,753.49 |
| Dr Reddys Laboratories Ltd |
1,219.60 |
-4.03 |
1,420.20 |
1,025.90 |
101,785.59 |
| Zydus Lifesciences Ltd |
948.95 |
-2.17 |
1,323.90 |
797.05 |
95,486.57 |
| Lupin Ltd |
1,865.45 |
-3.28 |
2,403.45 |
1,774.00 |
85,203.93 |
|
|
|
|